Mobile Menu

Search Results

Search results for: Drug Development

AlphaFold 3: Stepping into the future of structure prediction

We’ve all heard about the potential of artificial intelligence in the life sciences field. In 2020, the launch of AlphaFold […]

Genomics Week in Brief: Week Ending 17th May

We know there’s never a quiet week in the genomics world, that’s why in Week in Brief we’ve sourced the […]

Liquid Biopsy ONLINE

Multi-omics is rapidly becoming one of the most influential methods in the life sciences, poised to become the cornerstone technique of future research.  

In these early stages of progress, clear and informative dialogue between experts in the field is vital. No one has the time to read all the papers and preprints necessary to truly ‘stay ahead’. Therefore, a tailored webinar series such as this is the perfect opportunity to learn on the go. 

So, please join us for our next Multi-Omics ONLINE webinar series. This webinar series is a 3-part exploration of some of the most promising developments in multi-omics happening right now.

Highly Multiplexed Tissue Imaging to combat Tumour Heterogeneity

Tumours are complex entities and current pathological techniques do not capture that complexity. However, the new suite of spatial tools, […]

The State Of: Metabolomics

In the age of large-scale omics data, we often find ourselves discussing the merits of genomics, proteomics and transcriptomics. But […]

The Big Challenge… With Theo Alexandrov

With the ever-increasing potential of new technology and the exponential growth of the life sciences field, researchers are always running […]

Genetic Clues for PTSD and Major Depression Discovered

A recent study, published in The American Journal of Psychiatry, has shed light on the mechanisms behind the brain’s response to stress in those with post-traumatic stress disorder (PTSD) and major depressive disorder (MDD). The implications of this study are far-reaching, from improving our understanding of the cellular and molecular basis of PTSD and MDD to potentially revolutionizing the diagnosis and treatment of these challenging neuropsychiatric disorders. The findings open up exciting avenues for further research, personalized medicine, and the development of targeted therapeutic interventions.

The Festival of Genomics and Biodata: An interview with Serena Scollen, ELIXIR

At the Festival of Genomics and Biodata, we are lucky enough to be joined by some of the biggest names […]

The Festival of Genomics and Biodata: An interview with Matt Brown, CSO, Genomics England

At the Festival of Genomics and Biodata, we are lucky enough to be joined by some of the biggest names […]

Advanced Research Models ONLINE

We frequently read articles about how diseases have been reversed, halted and cured in mice, yet effective treatments for humans […]